Index RUT
P/E 99.54
EPS (ttm) 0.04
Insider Own 2.60%
Shs Outstand 156.35M
Perf Week -5.91%
Market Cap 686.88M
Forward P/E 10.98
EPS next Y 0.39
Insider Trans -5.46%
Shs Float 155.59M
Perf Month -14.00%
Income 9.21M
PEG -
EPS next Q 0.08
Inst Own 107.80%
Short Float 8.74%
Perf Quarter -29.39%
Sales 400.56M
P/S 1.71
EPS this Y 104.01%
Inst Trans -3.23%
Short Ratio 6.36
Perf Half Y -52.38%
Book/sh -2.01
P/B -
EPS next Y 51.61%
ROA 1.84%
Short Interest 13.60M
Perf Year -53.16%
Cash/sh 0.66
P/C 6.51
EPS next 5Y -
ROE -559.14%
52W Range 3.79 - 15.70
Perf YTD -62.41%
Dividend Est. -
P/FCF 4.69
EPS past 5Y -28.37%
ROI 2.92%
52W High -72.61%
Beta 0.49
Dividend TTM -
Quick Ratio 3.92
Sales past 5Y 5.56%
Gross Margin 99.49%
52W Low 13.46%
ATR (14) 0.32
Dividend Ex-Date -
Current Ratio 3.92
EPS Y/Y TTM 101.01%
Oper. Margin 32.83%
RSI (14) 39.32
Volatility 6.00% 6.58%
Employees 267
Debt/Eq -
Sales Y/Y TTM -6.25%
Profit Margin 2.30%
Recom 1.50
Target Price 12.12
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 99.92%
Payout -
Rel Volume 3.30
Prev Close 4.51
Sales Surprise -11.86%
EPS Surprise -106.41%
Sales Q/Q -12.09%
Earnings Aug 08 BMO
Avg Volume 2.14M
Price 4.30
SMA20 -7.66%
SMA50 -20.62%
SMA200 -49.67%
Trades
Volume 7,065,745
Change -4.66%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-09-24 Initiated
Leerink Partners
Market Perform
$5
Aug-08-24 Downgrade
CapitalOne
Overweight → Equal Weight
$12 → $4
Jan-17-24 Initiated
Craig Hallum
Buy
$21
Dec-14-23 Initiated
Wells Fargo
Overweight
$20
Nov-09-23 Initiated
Jefferies
Buy
$21
Sep-28-23 Initiated
JMP Securities
Mkt Outperform
$22
Sep-02-22 Initiated
CapitalOne
Overweight
$15
Apr-22-22 Initiated
Piper Sandler
Overweight
$16
Sep-30-20 Downgrade
Wells Fargo
Overweight → Equal Weight
$14 → $9
Jun-17-20 Initiated
Northland Capital
Outperform
$14
Jul-10-19 Resumed
Credit Suisse
Neutral
Mar-27-19 Upgrade
Morgan Stanley
Underweight → Equal-Weight
Feb-25-19 Upgrade
H.C. Wainwright
Sell → Neutral
$14
Jan-24-19 Upgrade
JP Morgan
Underweight → Neutral
Nov-07-18 Downgrade
JP Morgan
Neutral → Underweight
Nov-07-18 Downgrade
Credit Suisse
Outperform → Neutral
Jul-23-18 Initiated
H.C. Wainwright
Sell
$12.50
May-09-18 Downgrade
Morgan Stanley
Equal-Weight → Underweight
Jan-05-18 Downgrade
BofA/Merrill
Buy → Underperform
Dec-06-17 Downgrade
Mizuho
Buy → Neutral
$16
Show Previous Ratings
Sep-17-24 08:40AM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
04:01PM
Aug-09-24 10:56AM
08:15AM
Loading…
Aug-08-24 08:15AM
07:16AM
(Associated Press Finance)
07:00AM
Aug-01-24 10:01AM
Jul-25-24 04:00PM
Jul-17-24 08:30AM
Jul-08-24 07:00AM
Jun-12-24 07:00PM
Jun-10-24 07:00PM
May-30-24 04:01PM
06:00AM
Loading…
May-21-24 06:00AM
May-10-24 01:58PM
12:59PM
11:16AM
May-09-24 03:59PM
01:55PM
01:39PM
11:57AM
09:54AM
07:11AM
(Associated Press Finance)
07:00AM
May-06-24 04:01PM
May-02-24 02:33PM
10:01AM
May-01-24 07:30AM
01:16PM
Loading…
Apr-30-24 01:16PM
Apr-25-24 04:01PM
Apr-21-24 10:39AM
Mar-28-24 07:30AM
Mar-05-24 01:05PM
Feb-29-24 04:19PM
(Investor's Business Daily) -37.63%
08:37AM
06:26AM
06:08AM
06:00AM
Feb-23-24 07:30AM
Feb-16-24 10:15AM
09:36AM
Feb-15-24 10:45PM
(Thomson Reuters StreetEvents)
08:15AM
07:26AM
(Associated Press Finance)
07:00AM
Feb-05-24 08:50AM
Feb-01-24 04:01PM
Jan-23-24 09:55AM
Jan-08-24 07:00PM
06:00AM
Jan-03-24 04:01PM
Dec-12-23 04:01PM
Nov-30-23 09:45AM
Nov-21-23 04:01PM
Nov-10-23 02:45PM
11:09AM
Nov-09-23 10:25PM
(Thomson Reuters StreetEvents)
08:39AM
07:46AM
07:22AM
(Associated Press Finance)
07:00AM
Oct-26-23 04:01PM
Oct-23-23 07:30AM
Oct-17-23 12:02PM
Oct-16-23 06:00AM
Oct-05-23 07:30AM
Oct-03-23 11:43AM
Oct-01-23 07:15AM
Sep-26-23 11:48AM
Sep-20-23 07:36AM
Sep-19-23 12:08PM
11:39AM
Sep-12-23 08:32AM
Sep-07-23 11:30AM
Aug-12-23 08:50AM
Aug-09-23 09:24AM
Aug-08-23 11:12PM
(Thomson Reuters StreetEvents) -9.16%
11:05AM
09:56AM
07:00AM
Jul-28-23 02:56PM
Jul-25-23 04:01PM
Jun-29-23 08:30AM
Jun-21-23 08:00PM
Jun-16-23 07:00AM
Jun-13-23 09:18AM
Jun-12-23 04:05PM
09:54AM
May-25-23 10:32AM
May-23-23 12:07PM
May-22-23 05:43PM
04:08PM
(Investor's Business Daily)
01:11PM
(American City Business Journals)
12:02PM
08:40AM
07:24AM
07:22AM
06:57AM
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
John Minardo Chief Legal Officer Aug 12 '24 Sale 4.27 9,910 42,316 284,661 Aug 14 05:10 PM Silver Ronald Principal Accounting Officer Aug 12 '24 Sale 4.27 3,107 13,267 158,370 Aug 14 05:08 PM John Minardo Officer Aug 12 '24 Proposed Sale 4.05 11,726 47,490 Aug 09 04:05 PM McHugh Julie Director Jun 10 '24 Sale 6.29 22,766 143,198 139,528 Jun 12 04:05 PM Moukheibir Catherine Director Jun 06 '24 Sale 6.36 44,426 282,549 84,207 Jun 10 04:58 PM Moukheibir Catherine Director Jun 07 '24 Sale 6.61 35,574 235,144 48,633 Jun 10 04:58 PM MCCOURT Thomas A Chief Executive Officer May 20 '24 Sale 6.45 67,618 436,136 1,150,330 May 22 04:05 PM Davis Andrew SVP, Chief Business Officer May 20 '24 Sale 6.45 22,725 146,576 288,031 May 22 04:05 PM Shetzline Michael CMO,SVP,Head-Res&Drug May 20 '24 Sale 6.45 16,128 104,026 413,719 May 22 04:05 PM John Minardo Chief Legal Officer May 20 '24 Sale 6.45 17,404 112,256 294,571 May 22 04:05 PM John Minardo Chief Legal Officer Mar 08 '24 Option Exercise 0.00 32,752 0 311,975 Mar 12 04:05 PM Emany Sravan Kumar SVP, Chief Financial Officer Mar 08 '24 Option Exercise 0.00 37,120 0 338,853 Mar 12 04:05 PM Shetzline Michael CMO,SVP,Head-Res&Drug Mar 08 '24 Option Exercise 0.00 34,936 0 429,847 Mar 12 04:05 PM Davis Andrew SVP, Chief Business Officer Mar 08 '24 Option Exercise 0.00 37,120 0 310,756 Mar 12 04:05 PM MCCOURT Thomas A Chief Executive Officer Mar 08 '24 Option Exercise 0.00 120,298 0 1,217,948 Mar 12 04:05 PM Duane Jon R Director Mar 06 '24 Buy 8.70 6,920 60,204 121,028 Mar 08 04:05 PM Emany Sravan Kumar SVP, Chief Financial Officer Mar 04 '24 Buy 9.38 10,684 100,216 301,733 Mar 06 04:05 PM John Minardo Chief Legal Officer Feb 12 '24 Sale 15.24 47,380 722,071 224,796 Feb 14 09:01 PM Shetzline Michael CMO,SVP,Head-Res&Drug Feb 12 '24 Sale 15.24 38,618 588,538 340,484 Feb 14 08:53 PM Silver Ronald Principal Accounting Officer Feb 12 '24 Sale 15.24 7,908 120,518 134,264 Feb 14 08:50 PM Davis Andrew SVP, Chief Business Officer Feb 12 '24 Sale 15.24 9,846 150,053 208,324 Feb 14 08:42 PM MCCOURT Thomas A Chief Executive Officer Feb 12 '24 Sale 15.24 177,164 2,699,979 832,774 Feb 14 08:35 PM Kessler Marla L Director Dec 14 '23 Sale 11.19 9,926 111,072 96,572 Dec 18 04:09 PM Davis Andrew SVP, Chief Business Officer Nov 20 '23 Sale 9.69 3,287 31,851 217,374 Nov 22 04:05 PM
Index RUT
P/E 18.02
EPS (ttm) 6.11
Insider Own 2.53%
Shs Outstand 69.86M
Perf Week 4.26%
Market Cap 7.64B
Forward P/E 15.26
EPS next Y 7.21
Insider Trans -4.46%
Shs Float 67.67M
Perf Month 8.72%
Income 428.48M
PEG 0.48
EPS next Q 1.56
Inst Own 99.25%
Short Float 6.28%
Perf Quarter 39.13%
Sales 1.44B
P/S 5.31
EPS this Y 6.98%
Inst Trans -1.04%
Short Ratio 3.93
Perf Half Y 87.41%
Book/sh 14.51
P/B 7.58
EPS next Y 8.19%
ROA 26.15%
Short Interest 4.25M
Perf Year 77.61%
Cash/sh 10.90
P/C 10.09
EPS next 5Y 37.73%
ROE 54.26%
52W Range 50.20 - 126.89
Perf YTD 77.50%
Dividend Est. -
P/FCF 19.35
EPS past 5Y 35.30%
ROI 26.06%
52W High -13.27%
Beta 0.50
Dividend TTM -
Quick Ratio 4.41
Sales past 5Y 36.54%
Gross Margin 64.49%
52W Low 119.22%
ATR (14) 4.10
Dividend Ex-Date -
Current Ratio 4.68
EPS Y/Y TTM 1183.66%
Oper. Margin 31.47%
RSI (14) 61.73
Volatility 3.78% 4.03%
Employees 834
Debt/Eq 0.60
Sales Y/Y TTM 27.83%
Profit Margin 29.80%
Recom 1.17
Target Price 144.55
Option/Short Yes / Yes
LT Debt/Eq 0.60
EPS Q/Q -33.67%
Payout 0.00%
Rel Volume 1.07
Prev Close 108.56
Sales Surprise 3.13%
EPS Surprise -1.62%
Sales Q/Q 22.50%
Earnings Jul 31 BMO
Avg Volume 1.08M
Price 110.05
SMA20 4.47%
SMA50 3.70%
SMA200 43.12%
Trades
Volume 1,162,275
Change 1.37%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-03-24 Initiated
Redburn Atlantic
Buy
$175
Jul-10-24 Reiterated
JMP Securities
Mkt Outperform
$100 → $130
Dec-18-23 Downgrade
William Blair
Outperform → Mkt Perform
Dec-04-23 Initiated
TD Cowen
Outperform
$100
Sep-29-23 Initiated
William Blair
Outperform
Mar-08-23 Initiated
JMP Securities
Mkt Outperform
$120
Nov-30-22 Initiated
SVB Leerink
Outperform
Oct-13-22 Initiated
Mizuho
Buy
$105
May-09-22 Initiated
B. Riley Securities
Buy
$91
Apr-13-22 Initiated
Truist
Buy
$77
Feb-01-21 Initiated
SVB Leerink
Outperform
$24
Jun-29-20 Resumed
Jefferies
Buy
$29
Aug-16-19 Upgrade
CJS Securities
Market Perform → Market Outperform
Nov-02-17 Upgrade
Wells Fargo
Market Perform → Outperform
Nov-08-16 Reiterated
RBC Capital Mkts
Outperform
$6 → $12
Sep-23-16 Resumed
Credit Suisse
Neutral
Feb-24-16 Reiterated
RBC Capital Mkts
Outperform
$9 → $6
Dec-11-15 Downgrade
Credit Suisse
Outperform → Neutral
Sep-30-15 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-20-15 Initiated
Wells Fargo
Outperform
Show Previous Ratings
Sep-19-24 12:08PM
Sep-15-24 08:45AM
Sep-05-24 08:30AM
Aug-28-24 08:30AM
Aug-20-24 08:30AM
07:01PM
Loading…
Aug-14-24 07:01PM
Jul-31-24 07:13AM
(Associated Press Finance)
07:00AM
Jul-23-24 03:52AM
Jul-17-24 08:30AM
Jul-15-24 08:30AM
Jul-10-24 04:11PM
(Investor's Business Daily) +36.65%
+16.42%
12:32PM
11:57AM
Jul-08-24 08:30AM
06:48AM
Loading…
Jul-05-24 06:48AM
Jul-04-24 07:47AM
Jun-27-24 07:05AM
Jun-24-24 09:50AM
Jun-20-24 08:41PM
Jun-18-24 06:15PM
11:47AM
Jun-10-24 06:15PM
Jun-03-24 08:30AM
May-31-24 12:00PM
May-30-24 07:00PM
07:00PM
11:55AM
May-28-24 09:40AM
08:00AM
12:45PM
Loading…
May-27-24 12:45PM
09:55AM
May-24-24 09:45AM
May-20-24 09:00AM
May-15-24 04:30PM
07:00AM
May-07-24 09:00AM
May-03-24 12:36PM
12:24PM
09:31AM
03:04AM
May-02-24 11:14AM
10:30AM
09:14AM
08:35AM
07:32AM
(Associated Press Finance)
07:00AM
Apr-30-24 02:39PM
Apr-26-24 05:50PM
01:12PM
Apr-25-24 10:01AM
Apr-24-24 06:00PM
09:00AM
Apr-23-24 09:45AM
09:40AM
Apr-19-24 12:10PM
Apr-18-24 08:00AM
Apr-15-24 06:00PM
09:50AM
Apr-13-24 12:12PM
Apr-11-24 09:00AM
Apr-10-24 02:18PM
Apr-09-24 06:00PM
Apr-05-24 09:00AM
Apr-03-24 05:45PM
Mar-28-24 10:04AM
07:30AM
Mar-26-24 05:45PM
Mar-25-24 09:00AM
Mar-22-24 09:30AM
Mar-20-24 05:45PM
Mar-14-24 05:45PM
09:50AM
Mar-13-24 04:30PM
Mar-12-24 09:00AM
Mar-11-24 07:01PM
Mar-08-24 05:45PM
03:00AM
Mar-07-24 09:40AM
Mar-06-24 09:55AM
09:30AM
Mar-05-24 10:15AM
08:30AM
08:00AM
Mar-04-24 08:30AM
Feb-28-24 08:30AM
Feb-27-24 09:00AM
Feb-26-24 11:00AM
08:30AM
Feb-23-24 11:00AM
10:48AM
09:30AM
Feb-22-24 09:30AM
08:30AM
08:12AM
07:33AM
(Associated Press Finance)
07:00AM
03:55AM
Feb-19-24 09:55AM
09:30AM
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sabens Andrea Officer Sep 13 '24 Proposed Sale 104.10 341 35,498 Sep 13 01:29 PM Thrall James H Director Aug 21 '24 Sale 98.52 1,000 98,520 34,207 Aug 23 04:30 PM Thrall James H Director Aug 21 '24 Proposed Sale 98.52 1,000 98,520 Aug 21 09:51 AM Niedzwiecki Daniel See Remarks Aug 14 '24 Sale 97.54 2,500 243,850 77,744 Aug 16 04:30 PM Ber Gerard Director Aug 12 '24 Sale 96.48 15,500 1,495,396 21,221 Aug 14 04:56 PM Niedzwiecki Daniel Officer Aug 14 '24 Proposed Sale 97.54 2,500 243,850 Aug 14 12:41 PM Sabens Andrea Officer Aug 13 '24 Proposed Sale 97.83 341 33,360 Aug 13 10:59 AM Blanchfield Paul President Aug 08 '24 Sale 96.39 2,000 192,780 98,980 Aug 12 05:09 PM Gerard Ber Director Aug 12 '24 Proposed Sale 97.33 15,500 1,508,615 Aug 12 04:23 PM Blanchfield Paul Officer Aug 08 '24 Proposed Sale 96.39 2,000 192,780 Aug 08 11:16 AM Heino Mary Anne Director Aug 02 '24 Sale 95.50 10,481 1,000,900 454,923 Aug 06 04:30 PM Heino Mary Anne Officer Aug 02 '24 Proposed Sale 95.42 10,481 1,000,115 Aug 02 04:21 PM Sabens Andrea Chief Accounting Officer Jul 16 '24 Sale 124.96 1,796 224,423 60,420 Jul 17 04:30 PM Sabens Andrea Chief Accounting Officer Jul 15 '24 Sale 123.15 341 41,994 62,216 Jul 17 04:30 PM Pruden Gary J Director Jul 10 '24 Sale 95.04 12,530 1,190,851 11,978 Jul 12 04:30 PM Sabens Andrea Chief Accounting Officer Jun 13 '24 Sale 79.77 341 27,202 62,557 Jun 17 04:30 PM Blanchfield Paul President May 31 '24 Sale 80.82 1,179 95,287 101,498 Jun 04 04:30 PM Niedzwiecki Daniel See Remarks May 30 '24 Sale 79.86 12,873 1,028,038 80,244 Jun 03 04:30 PM Maeusli Heinz Christoph Director May 28 '24 Option Exercise 16.17 17,481 282,668 49,032 May 30 04:34 PM Maeusli Heinz Christoph Director May 28 '24 Sale 79.19 18,373 1,454,989 23,340 May 30 04:34 PM McHugh Julie Director May 28 '24 Sale 78.50 2,500 196,250 28,617 May 30 04:32 PM Sabens Andrea Chief Accounting Officer May 13 '24 Sale 76.89 341 26,219 62,898 May 15 05:09 PM Sabens Andrea Chief Accounting Officer Apr 15 '24 Sale 61.24 341 20,883 63,239 Apr 17 04:30 PM Marshall Robert J. Jr. CFO and Treasurer Mar 15 '24 Sale 60.00 20,000 1,200,000 113,749 Mar 19 04:30 PM Sabens Andrea Chief Accounting Officer Mar 13 '24 Sale 60.48 341 20,624 63,204 Mar 15 04:30 PM Blanchfield Paul President Mar 07 '24 Sale 61.96 18,023 1,116,705 103,357 Mar 11 04:30 PM Lantheus Alpha Therapy, LLC 10% Owner Mar 06 '24 Buy 0.95 60,431,039 57,409,487 116,773,394 Mar 08 11:24 AM LENO SAM R Director Mar 05 '24 Option Exercise 16.30 2,045 33,334 59,982 Mar 07 04:30 PM LENO SAM R Director Mar 06 '24 Option Exercise 16.30 2,045 33,334 59,982 Mar 07 04:30 PM LENO SAM R Director Mar 05 '24 Sale 64.62 2,045 132,148 57,937 Mar 07 04:30 PM LENO SAM R Director Mar 06 '24 Sale 63.50 2,045 129,857 57,937 Mar 07 04:30 PM LENO SAM R Director Mar 04 '24 Option Exercise 19.85 22,389 444,499 80,326 Mar 06 05:15 PM LENO SAM R Director Mar 04 '24 Sale 65.42 22,389 1,464,749 57,937 Mar 06 05:15 PM Heino Mary Anne Director Mar 04 '24 Sale 65.31 93,863 6,129,889 251,643 Mar 05 08:28 PM Sabens Andrea Chief Accounting Officer Feb 13 '24 Sale 55.31 341 18,861 58,403 Feb 15 04:30 PM Sabens Andrea Chief Accounting Officer Jan 16 '24 Sale 56.01 341 19,099 58,744 Jan 18 04:30 PM Marshall Robert J. Jr. CFO and Treasurer Dec 15 '23 Sale 78.24 10,000 782,400 103,170 Dec 19 05:00 PM Sabens Andrea Chief Accounting Officer Dec 13 '23 Sale 75.62 341 25,786 59,085 Dec 15 04:30 PM Blanchfield Paul President Nov 16 '23 Sale 67.96 1,500 101,940 88,651 Nov 20 04:30 PM Heino Mary Anne CEO Nov 13 '23 Sale 63.72 11,780 750,611 317,687 Nov 15 04:32 PM Sabens Andrea Chief Accounting Officer Nov 13 '23 Sale 63.57 341 21,677 59,426 Nov 15 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite